Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Lan Su

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Journal of the American Heart Association|December 11, 2025
Increased Cardiovascular Risk With Lorlatinib in Patients With ALK-Mutated Lung Cancer: A Real-World Comparative StudyChien-Yu Lin, Po-Lan Su, Chin-Wei Kuo, et al.
Frontiers in Oncology|October 5, 2020
An Observational Study of Acquired <i>EGFR</i> T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in TaiwanShang-Gin Wu, Chi-Lu Chiang, Chien-Ying Liu, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte RatioJeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, et al.
Therapeutic Advances in Medical Oncology|September 18, 2023
Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score studyChin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei, et al.
Biomedicines|March 6, 2021
Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLCChien-Chung Lin, Chin-You Wu, Joseph T Tseng, et al.
Scientific Reports|May 16, 2023
Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expressionChin-Wei Kuo, Po-Lan Su, Tang-Hsiu Huang, et al.
Frontiers in Oncology|September 6, 2023
Low neutrophil-to-lymphocyte ratio predicts overall survival benefit in advanced NSCLC patients with low PD-L1 expression and receiving chemoimmunotherapyChian-Wei Chen, Chien-Yu Lin, Jeng-Shiuan Tsai, et al.
Therapeutic Advances in Medical Oncology|September 29, 2018
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancerPo-Lan Su, Yi-Lin Wu, Wei-Yuan Chang, et al.
Frontiers in Oncology|August 29, 2022
Case report: Salvage capmatinib therapy in <i>KIF5B-MET</i> fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotinChien-Yu Lin, Sheng-Huan Wei, Yi-Lin Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 12, 2021
Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients - A retrospective cohort studyChin-Wei Kuo, Sheng-Yuan Wang, Huey-Pin Tsai, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of the American Heart Association|December 11, 2025
Increased Cardiovascular Risk With Lorlatinib in Patients With ALK-Mutated Lung Cancer: A Real-World Comparative StudyChien-Yu Lin, Po-Lan Su, Chin-Wei Kuo, et al.
Frontiers in Oncology|October 5, 2020
An Observational Study of Acquired <i>EGFR</i> T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in TaiwanShang-Gin Wu, Chi-Lu Chiang, Chien-Ying Liu, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte RatioJeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, et al.
Therapeutic Advances in Medical Oncology|September 18, 2023
Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score studyChin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei, et al.
Biomedicines|March 6, 2021
Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLCChien-Chung Lin, Chin-You Wu, Joseph T Tseng, et al.
Scientific Reports|May 16, 2023
Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expressionChin-Wei Kuo, Po-Lan Su, Tang-Hsiu Huang, et al.
Frontiers in Oncology|September 6, 2023
Low neutrophil-to-lymphocyte ratio predicts overall survival benefit in advanced NSCLC patients with low PD-L1 expression and receiving chemoimmunotherapyChian-Wei Chen, Chien-Yu Lin, Jeng-Shiuan Tsai, et al.
Therapeutic Advances in Medical Oncology|September 29, 2018
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancerPo-Lan Su, Yi-Lin Wu, Wei-Yuan Chang, et al.
Frontiers in Oncology|August 29, 2022
Case report: Salvage capmatinib therapy in <i>KIF5B-MET</i> fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotinChien-Yu Lin, Sheng-Huan Wei, Yi-Lin Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 12, 2021
Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients - A retrospective cohort studyChin-Wei Kuo, Sheng-Yuan Wang, Huey-Pin Tsai, et al.
Pageof 7